Walgreens Boots (NASDAQ:WBA) pared a bit of its decline amid a report that private equity firm Sycamore Partners is talking ...
Walgreens Boots Alliance Inc.’s chairman and biggest shareholder, Stefano Pessina, has dealmaking in his DNA. Yet finding a ...
Sycamore Partners has been speaking with private credit firms about debt financing for a potential deal, despite an earlier report that takeover talks had stalled.
A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...
Walgreens ( NASDAQ: WBA) has to consider and evaluate all options as part of its fiduciary duty, CEO Tim Wentworth said in ...
Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In ...
"The company's cash needs over the next several years, including with respect to litigation and debt refinancing, were ...
Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...
The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be ...
Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely ...
Earlier in December, the WSJ reported that Sycamore Partners was in talks to take Walgreens private. However, Walgreens CEO Tim Wentworth on Thursday, in response to questions on takeover ...